
### [NCIT:C8984](http://purl.obolibrary.org/obo/NCIT_C8984)
**Label:** Female Reproductive System Adenofibroma

**Subclasses:** [NCIT:C8979](http://purl.obolibrary.org/obo/NCIT_C8979) (Mucinous Cystadenofibroma), [NCIT:C67090](http://purl.obolibrary.org/obo/NCIT_C67090) (Serous Adenofibroma), [NCIT:C8978](http://purl.obolibrary.org/obo/NCIT_C8978) (Mucinous Adenofibroma), [NCIT:C6337](http://purl.obolibrary.org/obo/NCIT_C6337) (Uterine Corpus Adenofibroma), [NCIT:C40029](http://purl.obolibrary.org/obo/NCIT_C40029) (Borderline Ovarian Serous Cystadenofibroma), [NCIT:C40028](http://purl.obolibrary.org/obo/NCIT_C40028) (Borderline Ovarian Serous Adenofibroma), [NCIT:C40069](http://purl.obolibrary.org/obo/NCIT_C40069) (Borderline Ovarian Endometrioid Adenofibroma), [NCIT:C40085](http://purl.obolibrary.org/obo/NCIT_C40085) (Ovarian Clear Cell Adenofibroma), [NCIT:C40041](http://purl.obolibrary.org/obo/NCIT_C40041) (Ovarian Mucinous Cystadenofibroma), [NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma), [NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma), [NCIT:C40040](http://purl.obolibrary.org/obo/NCIT_C40040) (Ovarian Mucinous Adenofibroma), [NCIT:C40081](http://purl.obolibrary.org/obo/NCIT_C40081) (Borderline Ovarian Clear Cell Adenofibroma), [NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma), [NCIT:C27289](http://purl.obolibrary.org/obo/NCIT_C27289) (Borderline Ovarian Endometrioid Cystadenofibroma), [NCIT:C27288](http://purl.obolibrary.org/obo/NCIT_C27288) (Ovarian Endometrioid Cystadenofibroma), [NCIT:C8988](http://purl.obolibrary.org/obo/NCIT_C8988) (Clear Cell Cystadenofibroma), [NCIT:C27287](http://purl.obolibrary.org/obo/NCIT_C27287) (Ovarian Endometrioid Adenofibroma), [NCIT:C8986](http://purl.obolibrary.org/obo/NCIT_C8986) (Papillary Adenofibroma), [NCIT:C8987](http://purl.obolibrary.org/obo/NCIT_C8987) (Clear Cell Adenofibroma), [NCIT:C8985](http://purl.obolibrary.org/obo/NCIT_C8985) (Cystadenofibroma), [NCIT:C40113](http://purl.obolibrary.org/obo/NCIT_C40113) (Fallopian Tube Serous Adenofibroma), [NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma), [NCIT:C40230](http://purl.obolibrary.org/obo/NCIT_C40230) (Cervical Adenofibroma), [NCIT:C126478](http://purl.obolibrary.org/obo/NCIT_C126478) (Broad Ligament Serous Adenofibroma), [NCIT:C40032](http://purl.obolibrary.org/obo/NCIT_C40032) (Ovarian Serous Cystadenofibroma), [NCIT:C126477](http://purl.obolibrary.org/obo/NCIT_C126477) (Broad Ligament Serous Cystadenofibroma), [NCIT:C40031](http://purl.obolibrary.org/obo/NCIT_C40031) (Ovarian Serous Adenofibroma), [NCIT:C126311](http://purl.obolibrary.org/obo/NCIT_C126311) (Ovarian Seromucinous Adenofibroma), 

**Class expressions from DL-Learner:**

- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37115](http://purl.obolibrary.org/obo/NCIT_C37115) (Serous Adenocarcinoma Cell))) 57.14%
- Thing 52.69%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 48.94%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 48.65%
- [NCIT:C36753](http://purl.obolibrary.org/obo/NCIT_C36753) (Neoplastic Epithelial Cell) 45.67%
- [NCIT:C36745](http://purl.obolibrary.org/obo/NCIT_C36745) (Abnormal Epithelial Cell) 45.64%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 42.50%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39628](http://purl.obolibrary.org/obo/NCIT_C39628) (Single Cell Exocytosis))) 42.50%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39627](http://purl.obolibrary.org/obo/NCIT_C39627) (Pautrier Microabscess Present))) 42.50%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39626](http://purl.obolibrary.org/obo/NCIT_C39626) (Epidermotropic Lymphocytic Infiltrate))) 42.50%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39625](http://purl.obolibrary.org/obo/NCIT_C39625) (Extracutaneous Dissemination of Disease))) 42.50%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39624](http://purl.obolibrary.org/obo/NCIT_C39624) (Skin Plaque))) 42.50%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39622](http://purl.obolibrary.org/obo/NCIT_C39622) (Scaly Skin Eruption))) 42.50%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39620](http://purl.obolibrary.org/obo/NCIT_C39620) (Dermatopathic Lymphadenopathy))) 42.50%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39618](http://purl.obolibrary.org/obo/NCIT_C39618) (Subcutaneous Nodule))) 42.50%


